Ciedon is a biotech startup developing targeted cancer therapies by focusing on a powerful yet often overlooked mechanism: calcium signaling. Calcium plays a critical role in regulating how cells grow, divide, and survive—functions that cancer exploits to spread and resist treatment. Our platform is built on the science of disrupting these calcium-driven pathways at their origin. By cutting off the calcium signals that drive tumor progression, we're creating a new class of therapies that are both precise and potent, with fewer side effects than traditional treatments. The approach is bold but clear: Stop the Calcium, Stop the Cancer
| Website | https://www.ciedon.com |
| Employees | 3 (1 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
Looking for a particular Ciedon employee's phone or email?
Bill Schweitzer is the COO of Ciedon.
1 people are employed at Ciedon.